Green shoots of cannabis are seen in a field overlooking a lake in Yammouneh in West of Baalbek

South Africa's AfriAg seeks UK medical cannabis producer license

(Reuters) - AfriAg Global Plc has hired a law firm to help with the application process to become a licensed medical cannabis cultivator and producer in the UK, the South African haulier said on Monday.

Britain proposed in July to allow doctors to prescribe medicinal cannabis starting this year and several countries, including Germany, Italy and Denmark, already allow the prescription of medicinal cannabis and Canada recently became the second country in the world to fully legalise marijuana.

The decision in Britain followed the high-profile case of a 12-year-old boy with severe epilepsy who was denied access to cannabis oil, prompting a national debate and reviews by experts. Recreational use of cannabis is still prohibited in the country.

Evidence is growing that medical Marijuana can help with epilepsy and other conditions, such as chronic pain, multiple sclerosis and chemotherapy-induced nausea.

The UK was the main producer and exporter of cannabis-based medicines in 2016, according to a report by the UN's International Narcotics Control Board.

AfriAg, which supplies supermarkets and wholesalers with fresh African fruit, said the "highly regulated" application process would take some time and it might bring in other partners to assist with the process.

"The board see a huge opportunity here for AfriAg Global to help the UK increase its global market presence in this ... fast-growing sector," Executive Chairman David Lenigas said.

(Reporting by Noor Zainab Hussain in Bengaluru; Editing by Amrutha Gayathri)

2018-09-17 10:13:29

© 2018 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.